Join Meeting Now

Your data is secure and never shared.

Saudi Arabia
July 2026

KSA Artificial Intelligence in Healthcare Market Size, Share & Forecast, By Solution Type, Deployment Model & Application, 2026-2031

2031

The KSA Artificial Intelligence in Healthcare Market worth USD 88 million in 2025 is growing at a CAGR of 24.70% to reach USD 331 million by 2031. GE HealthCare, Siemens Healthineers, Philips, Microsoft and Lean Business Services are the major companies operating in this market.

Report Details

Base Year

2025

Pages

85

Region

Saudi Arabia

Author

Ken Research

Product Code
KR-RPT-V02-03822

CHAPTER 1 - MARKET SUMMARY

Market Overview

The KSA Artificial Intelligence in Healthcare Market operates through enterprise software licenses, AI-enabled medical devices, cloud infrastructure, implementation services and usage-based clinical applications. Demand is concentrated in high-value workflows where measurable clinical or operational returns are available. In 2024, 72% of surveyed Saudi health leaders reported AI implementation in treatment planning and 59% in remote patient monitoring, strengthening the commercial case for integrated clinical platforms.

Riyadh is the principal purchasing, regulatory and technology hub because it hosts national health authorities, public-sector health clusters, large hospital groups and digital-health platform headquarters. National virtual-care infrastructure reinforces this concentration while extending demand beyond the capital. Seha Virtual Hospital supports more than 242 hospitals, covers 48 main specialties and 68 subspecialties, and has annual capacity exceeding 597,000 beneficiaries.

Market Value

USD 88 million

2025

Dominant Region

Riyadh Region

2025

Dominant Segment

Medical Imaging and Diagnostics

2025; Virtual Care and Remote Monitoring fastest growing

Total Number of Players

45

Future Outlook

The KSA Artificial Intelligence in Healthcare Market is projected to expand from USD 88 million in 2025 to USD 331 million by 2031. The historical CAGR of 22.4% during 2020-2025 reflected rapid digitization, virtual-care deployment, imaging modernization and early clinical-AI procurement. Growth is expected to accelerate to a 24.70% forecast CAGR as buyers move from proofs of concept toward enterprise licenses, managed AI services and embedded algorithms. Increasing cloud adoption, stronger health-data interoperability and greater use of AI in treatment planning, preventive care and operational automation will enlarge both deployment volumes and average contract values.

Active enterprise AI deployments are forecast to increase from approximately 1,420 in 2025 to 3,970 by 2031, representing volume growth of about 18.8% annually. The remaining value expansion is expected to come from higher software content, integration complexity, clinical validation, cybersecurity services and recurring model-monitoring contracts. Cloud-hosted workloads are projected to rise from 58% to 84% during the period, while average annual revenue per active deployment increases from about USD 62,000 to USD 83,400. The principal upside trigger is coordinated procurement across health clusters; the main downside risk is delayed interoperability and clinical-governance implementation.

24.70%

Forecast CAGR

USD 331 Mn

2030 Projection

Base Year

2025

Historical Period

2020-2025

Forecast Period

2026-2031

Historical CAGR

22.4%

CHAPTER 2 - SCOPE OF REPORT

Scope of the Market

Click to Explore Interactive Mind Map

CHAPTER 3 - Key Stakeholders

Key Target Audience

Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.

Investors

CAGR, recurring revenue, clinical validation, regulatory risk, scalability

Corporates

deployment ROI, interoperability, cybersecurity, workflow productivity, vendor selection

Government

health access, data sovereignty, AI governance, workforce productivity

Operators

clinician adoption, model accuracy, integration cost, service uptime

Financial institutions

contract visibility, customer concentration, cash conversion, technology risk

What You'll Gain

  • Market sizing and trajectory
  • Clinical adoption benchmarks
  • Regulatory pathway mapping
  • Segment economics and opportunities
  • Competitive landscape shortlist
  • CEO-grade risk priorities

80+

Pages of insights

CHAPTER 4 - Market Size & Growth

Market Size, Growth Forecast and Trends

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.

Historical & Projected Market Size ($ Million)

Year-over-Year Growth Rate (%)

Market Value vs Volume Growth (%)

Historical Market Performance (2020-2025)

Historical performance was characterized by an initial virtual-care expansion followed by broader enterprise deployment. Active AI implementations increased from approximately 560 in 2020 to 1,420 in 2025, while AI-enabled clinical sites expanded from 145 to 410. The lowest annual value growth occurred in 2021 at 18.8%, when deployments remained concentrated in telehealth and imaging. The strongest inflection emerged in 2022-2023 as cloud infrastructure, clinical decision support and national platform connectivity widened. Demand remained concentrated among public health clusters, large private hospital groups and diagnostic-imaging networks with sufficient data volumes and integration budgets.

Forecast Market Outlook (2026-2031)

Forecast growth will be supported by simultaneous deployment expansion and higher-value solution mix. Active deployments are projected to reach 3,970 by 2031, while AI-enabled sites rise to approximately 1,200. Average annual revenue per active deployment is expected to increase from about USD 62,000 in 2025 to USD 83,400 in 2031 as managed integration, sovereign hosting, cybersecurity, model monitoring and clinical-validation requirements become embedded in contracts. Cloud-hosted workloads are forecast to account for 84% of activity by 2031. Growth should remain strongest in remote monitoring, workflow copilots, imaging orchestration and population-health risk prediction.

CHAPTER 5 - Market Data

Market Breakdown

The market's 24.70% forecast growth trajectory reflects expansion in deployed algorithms, participating clinical sites and cloud-based workloads. These indicators show whether suppliers are capturing scalable recurring revenue or remaining dependent on isolated implementation projects.

Market Breakdown

Historical Data (2020-2024) • Base Data (2025) • Forecast Data (2026-2031)

Year
Market Size (USD Mn)
YoY Growth (%)
Active AI Deployments
AI-Enabled Clinical Sites
Cloud-Hosted Workload Share
Period
2020$32 Mn+-560145
$#%
Forecast
2021$38 Mn+18.8%665175
$#%
Forecast
2022$47 Mn+23.7%795215
$#%
Forecast
2023$58 Mn+23.4%965265
$#%
Forecast
2024$71 Mn+22.4%1,160330
$#%
Forecast
2025$88 Mn+23.9%1,420410
$#%
Forecast
2026$110 Mn+25.0%1,690500
$#%
Forecast
2027$137 Mn+24.5%2,015605
$#%
Forecast
2028$171 Mn+24.8%2,395730
$#%
Forecast
2029$213 Mn+24.6%2,840870
$#%
Forecast
2030$265 Mn+24.4%3,3601,025
$#%
Forecast
2031$331 Mn+24.9%3,9701,200
$#%
Forecast

Active AI Deployments

1,420 deployments, 2025, KSA. Deployment density indicates monetization breadth across clinical and administrative workflows. Survey evidence shows AI already implemented in treatment planning at 72% of organizations, in-hospital monitoring at 72% and remote monitoring at 59%.

AI-Enabled Clinical Sites

410 sites, 2025, KSA. Site expansion determines recurring integration, support and model-monitoring revenue. Seha Virtual Hospital alone supports more than 242 hospitals and offers 48 main specialties plus 68 subspecialties, demonstrating the addressable scale for distributed clinical AI.

Cloud-Hosted Workload Share

58%, 2025, KSA. Cloud migration improves deployment speed and multi-site scalability but increases requirements for sovereignty, cybersecurity and interoperability. Lean and Google Cloud infrastructure supports services across more than 24,000 medical institutions, providing a national base for repeatable AI distribution.

CHAPTER 6 - Segmentation

Market Segmentation Framework

Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.

No of Segments

7

Dominant Segment

Application

Fastest Growing Segment

Deployment Model

Solution Type

Software Platforms
$%
AI-Enabled Medical Devices
$%
Managed AI Services
$%
Compute and Data Infrastructure
$%

Deployment Model

Cloud-Native Deployment
$%
On-Premise Deployment
$%
Hybrid Deployment
$%
Embedded AI Deployment
$%

End-Use Industry

Healthcare Providers
$%
Health Insurers and TPAs
$%
Pharmaceutical and Biotechnology Companies
$%
Public Health Agencies
$%
Research and Academic Institutions
$%

Enterprise Size

National and Large Health Systems
$%
Mid-Sized Provider Networks
$%
Standalone Clinics and Laboratories
$%
Digital Health Startups
$%

Application

Medical Imaging and Diagnostics
$%
Clinical Decision Support
$%
Virtual Care and Remote Monitoring
$%
Administrative Automation
$%
Drug Discovery and Population Health
$%

Pricing Model

Subscription SaaS
$%
Per-Study and Per-Transaction
$%
Enterprise License
$%
Managed Service and Outcome-Based
$%

Geography

Riyadh Region
$%
Makkah Region
$%
Eastern Province
$%
Madinah Region
$%
Other Regional Clusters
$%

Key Segmentation Takeaways

Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.

Application

Application is the dominant strategic dimension because purchasing decisions are tied directly to clinical outcomes, labor savings and workflow economics. Medical Imaging and Diagnostics leads commercial deployment due to high data availability, established PACS integration and measurable turnaround-time improvements. Clinical Decision Support and Administrative Automation extend the profit pool through recurring software, monitoring and enterprise-integration revenue.

Deployment Model

Deployment Model is the fastest-growing dimension as providers move from isolated on-premise pilots toward cloud-native, hybrid and embedded architectures. Hybrid Deployment is gaining relevance where sensitive patient data and inference remain local while model training, analytics and monitoring use scalable cloud resources. Sovereign hosting, interoperable APIs and device-embedded algorithms will increasingly determine procurement eligibility and contract value.

CHAPTER 7 - Regional Analysis

Regional Analysis

KSA ranks second among selected GCC peer countries by 2025 artificial intelligence in healthcare revenue, behind the UAE but ahead of Qatar, Kuwait, Oman and Bahrain. Its position is supported by greater population scale, national health-platform investment and centralized virtual-care infrastructure, while peer-country values are harmonized using healthcare expenditure, digital maturity and market-adoption inputs.

Regional Ranking

2nd

Focus Country Market Size

USD 88 Mn

KSA CAGR (2026-2031)

24.70%

Regional Analysis (Current Year)

Regional Analysis Comparison

MetricSaudi ArabiaUnited Arab EmiratesQatarKuwaitOmanBahrain
Market Size (USD Mn, 2025)8811234292113
CAGR (2026-2031)24.70%27.8%23.6%21.4%22.0%20.5%
Current Health Expenditure Per Capita (USD, 2023)1,4202,3502,9002,1001,1801,176
Physicians per 1,000 People (Latest)3.03.12.92.72.11.0

Market Position

KSA ranks second among the six selected GCC peers with USD 88 million in 2025 revenue, supported by a healthcare system serving more than 35 million residents and national-scale digital platforms.

Growth Advantage

KSA's 24.70% forecast CAGR exceeds Kuwait's 21.4%, Oman's 22.0% and Bahrain's 20.5%, positioning it as a regional growth leader behind the more digitally mature UAE market.

Competitive Strengths

Competitive strengths include 242-plus hospitals connected to Seha Virtual Hospital, infrastructure supporting 24,000-plus medical institutions and NPHIES connectivity across more than 5,000 providers.

CHAPTER 8 - INDUSTRY ANALYSIS

Growth Drivers, Challenges & Opportunities

Comprehensive analysis of key factors shaping the KSA Artificial Intelligence in Healthcare Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.

Growth Drivers

Clinical AI and Virtual Care Adoption

  • AI is implemented in in-hospital monitoring by 72% (2024, KSA) of surveyed organizations, creating recurring demand for algorithm licensing, clinical integration, data pipelines and model monitoring across hospital networks.
  • Remote patient monitoring has been implemented by 59% (2024, KSA) of respondents, extending revenue opportunities from episodic hospital purchases to continuous chronic-care monitoring, connected devices and subscription-based analytics.
  • Seha Virtual Hospital can support more than 597,000 beneficiaries annually (2026, KSA), allowing AI vendors to distribute specialist decision support and triage capabilities across geographically dispersed hospitals without duplicating specialist capacity.

National Health Data and Interoperability Scale

  • NPHIES connects more than 5,000 providers (2025, KSA), creating standardized transaction flows that support claims analytics, fraud detection, clinical coding automation and payer-provider decision tools.
  • The platform supports healthcare interactions for more than 30 million people (2025, KSA), providing population-scale data potential for risk stratification, utilization management and preventive-care programs when privacy and governance controls are applied.
  • Seha Virtual Hospital covers 48 main specialties and 68 subspecialties (2026, KSA), widening the number of clinical pathways in which AI triage, decision support and remote collaboration can be commercialized.

Policy-Backed AI Commercialization

  • Saudi Arabia's National Strategy for Data and AI establishes a national framework for AI capability, investment and sector deployment, giving healthcare suppliers a policy-aligned route to local partnerships and public-sector demand from 2020 onward (KSA).
  • SFDA guidance issued in 2023 (KSA) defines authorization requirements for AI and machine-learning medical devices, reducing regulatory ambiguity for clinically validated vendors while increasing barriers for untested entrants.
  • Digital-health product guidance updated in 2025 (KSA) strengthens expectations for classification, evidence, cybersecurity and post-market controls, expanding demand for regulatory affairs, validation and managed compliance services.

Market Challenges

Fragmented Data and Workflow Integration

  • Integration problems reduce available patient time for 34% (2024, KSA) of respondents, weakening expected productivity gains and requiring vendors to budget for workflow redesign rather than technology deployment alone.
  • Disconnected data contributes to repeated tests for 33% (2024, KSA) of surveyed organizations, increasing operating costs and limiting model accuracy where prior imaging, laboratory and medication histories cannot be accessed reliably.
  • Impaired decision-making affects 30% (2024, KSA) of respondents, making interoperability, terminology mapping and data-quality assurance critical commercial requirements for implementation partners and platform vendors.

Clinical Trust, Bias and Regulatory Burden

  • Transparency and interpretability are identified as important by 46% (2024, KSA) of health leaders, increasing demand for explainable models, audit trails and clinician-facing evidence rather than black-box performance claims.
  • Continuous education and training are prioritized by 45% (2024, KSA), meaning suppliers must fund change management, clinical onboarding and competency programs that lengthen sales cycles but improve retention.
  • SFDA authorization requirements introduced through dedicated AI and machine-learning guidance in 2023 (KSA) raise evidence, cybersecurity and post-market obligations, increasing compliance costs for smaller developers.

Workforce Capacity and Change Management

  • Staff shortages increase the likelihood of employee departures for 43% (2024, KSA) of surveyed organizations, reducing the availability of clinical champions required to validate and scale new AI workflows.
  • Automation is nevertheless viewed as critical or time-saving by 92% (2024, KSA), creating a requirement for suppliers to prove immediate workflow relief rather than rely on long-term transformation narratives.
  • Virtual care produces a positive staffing impact according to 100% (2024, KSA) of surveyed leaders, but benefits depend on redesigned scheduling, escalation protocols and workforce accountability across remote and physical care teams.

Market Opportunities

Arabic Clinical Copilots and Workflow Automation

  • Arabic clinical documentation, coding and summarization can monetize through per-user or enterprise subscriptions, with automation prioritized by 92% (2024, KSA) of leaders seeking time savings and operational capacity.
  • Providers and health clusters benefit through lower administrative burden and faster patient throughput, while vendors capture recurring revenue when copilots are embedded across 24,000-plus medical institutions (2023, KSA).
  • Commercial scale requires validated Arabic medical terminology, role-based access and human review aligned with the 6 SDAIA AI ethics principles assessed in this report (2023, KSA), including fairness, transparency, accountability, privacy, safety and humanity.

Chronic Disease Prediction and Population Screening

  • Risk-based screening can be monetized through payer contracts, public-health programs and managed analytics because 59% of tested high-risk participants (2025, KSA) showed abnormal glucose results.
  • Health clusters, insurers and employers benefit from earlier intervention and lower avoidable utilization when models achieve an AUROC of 0.803 (2025, KSA) in population risk classification.
  • Opportunity realization requires linked laboratory, claims and longitudinal records across more than 5,000 NPHIES-connected providers (2025, KSA), supported by consent, bias testing and clinical escalation pathways.

Managed AI and Sovereign Cloud Services

  • Managed hosting, model operations, cybersecurity and compliance services create recurring revenue beyond software licensing as cloud-hosted workloads rise from 58% to 84% (2025-2031, KSA forecast).
  • Hospitals, AI developers and research organizations benefit from domestic compute and lower deployment latency, while infrastructure providers gain utilization from more than 24,000 addressable medical institutions (2023, KSA).
  • Commercialization requires sovereign architecture, clinical-grade security and biomedical partnerships; a 2026 collaboration (KSA) between Lean and Flagship Pioneering targets AI-enabled biomedical research and healthcare innovation.

CHAPTER 9 - Competitive Landscape

Competitive Landscape Overview

Competition is moderately concentrated around multinational imaging, cloud and enterprise-health platforms, while Saudi digital-health firms compete through Arabic capability, national data integration and proximity to regulated public-sector procurement.

Market Share Distribution

GE HealthCare
Siemens Healthineers
Philips
Microsoft

Top 5 Players

1
GE HealthCare
!$*
2
Siemens Healthineers
^&
3
Philips
#@
4
Microsoft
$
5
Oracle Health
&@$
Combined Share$%

Market Dynamics

Local Players70%
Regional/Int'l30%

8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.

Company Profiles (Top 10 Players)
Company Name
Market Share
Headquarters
Founding Year
Core Market Focus
GE HealthCare
-Chicago, United States2023AI-enabled imaging, PACS, workflow orchestration and clinical analytics.
Siemens Healthineers
-Erlangen, Germany2017AI-supported imaging systems, radiology applications and enterprise diagnostic workflows.
Philips
-Amsterdam, Netherlands1891Connected care, imaging informatics, monitoring and clinical decision-support solutions.
Microsoft
-Redmond, United States1975Healthcare cloud, generative AI, data platforms and enterprise productivity copilots.
Oracle Health
-Kansas City, United States1979Electronic health records, healthcare data platforms, automation and embedded AI.
Google Cloud
-Mountain View, United States2008Healthcare data infrastructure, generative AI, analytics and scalable model deployment.
Lean Business Services
-Riyadh, Saudi Arabia2017National health-data platforms, AI risk prediction, interoperability and digital-health services.
Altibbi
-Amman, Jordan2008Arabic digital health, teleconsultation and AI-enabled patient-engagement services.
Nala
-Riyadh, Saudi Arabia2018Arabic medical AI, symptom assessment and digital primary-care support.
Cura
-Riyadh, Saudi Arabia2016On-demand telehealth, digital clinical workflows and remote-care services.

Cross Comparison Parameters

The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.

1

Clinical AI Deployment Footprint

2

Regulatory-Cleared Algorithm Portfolio

3

Saudi Healthcare Revenue Growth

4

Recurring Software Gross Margin

Analysis Covered

Market Share Analysis:

Compares supplier scale across clinical, cloud and service revenue pools.

Cross Comparison Matrix:

Benchmarks deployment reach, approvals, growth and recurring software economics.

SWOT Analysis:

Evaluates capabilities, constraints, opportunities and market-specific competitive exposure comprehensively.

Pricing Strategy Analysis:

Assesses subscription, transaction, license and outcome-based pricing structures comparatively.

Company Profiles:

Reviews market focus, geographic presence and differentiated healthcare capabilities.

CHAPTER 10 - REPORT TOC

Table of Contents

85Pages
34Chapters
10Companies Profiled
7Segmentation Types

Phase 1
Market Assessment Phase

11

Chapters

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

Phase 2
Go-To-Market Strategy Phase

15

Chapters

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

Complete Report Coverage

201+ detailed sections covering every aspect of the market

143

Assessment Sections

58

Strategy Sections

CHAPTER 11 - Our Approach

Research Methodology

Desk Research

  • Reviewed Saudi digital-health policies
  • Mapped AI medical-device authorizations
  • Assessed health-platform operating statistics
  • Benchmarked healthcare AI vendor portfolios

Primary Research

  • Interviewed hospital chief information officers
  • Engaged clinical informatics and radiology leaders
  • Consulted health-data platform architects
  • Surveyed payer transformation and procurement executives

Validation and Triangulation

  • Structured 300-respondent validation framework
  • Reconciled supplier and deployment estimates
  • Cross-checked clinical-site adoption ratios
  • Validated pricing through contract benchmarks

CHAPTER 12 - FAQ

FAQs

Still have questions?

Our research team is here to help you find the right solution

Contact Research Team

CHAPTER 13 - Related Research

Explore Related Reports

Expand your market intelligence with complementary research across regions and adjacent markets.

Regional/Country Reports

Related market analysis across key regions

  • Indonesia Artificial Intelligence in Healthcare Market
  • Vietnam Artificial Intelligence in Healthcare Market
  • Thailand Artificial Intelligence in Healthcare Market
  • Malaysia Artificial Intelligence in Healthcare Market
  • Philippines Artificial Intelligence in Healthcare Market

Adjacent Reports

Related markets and complementary research

500+

Market Research Reports

50+

Countries Covered

15+

Industry Verticals

Want the full report and an analyst walkthrough?

Unlock the complete dataset, segmentation cuts, and competitive analysis—plus a discovery call that maps insights to your go-to-market priorities.

;